HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Monari Selected Research

Photosensitivity Disorders (Photodermatitis)

1/2022The Behavior of Triplet Thymine in a Model B-DNA Strand. Energetics and Spin Density Localization Revealed by ab initio Molecular Dynamics Simulations.
11/2020Experimental and theoretical studies on thymine photodimerization mediated by oxidatively generated DNA lesions and epigenetic intermediates.
10/2018Triplet photosensitization mechanism of thymine by an oxidized nucleobase: from a dimeric model to DNA environment.
8/2017Deciphering the photosensitization mechanisms of hypericin towards biological membranes.
1/2017Ibuprofen and ketoprofen potentiate UVA-induced cell death by a photosensitization process.
7/2016Two-photon-absorption DNA sensitization via solvated electron production: unraveling photochemical pathways by molecular modeling and simulation.
3/2016Hydrogen abstraction by photoexcited benzophenone: consequences for DNA photosensitization.
2/2016Benzophenone Ultrafast Triplet Population: Revisiting the Kinetic Model by Surface-Hopping Dynamics.
1/2016From non-covalent binding to irreversible DNA lesions: nile blue and nile red as photosensitizing agents.
8/2015DNA Photosensitization by an "Insider": Photophysics and Triplet Energy Transfer of 5-Methyl-2-pyrimidone Deoxyribonucleoside.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Monari Research Topics

Disease

12Photosensitivity Disorders (Photodermatitis)
01/2022 - 02/2015
11Neoplasms (Cancer)
11/2022 - 03/2014
4Virus Diseases (Viral Diseases)
05/2022 - 07/2020
4COVID-19
02/2022 - 11/2020
2Hypoxia (Hypoxemia)
11/2022 - 11/2019
1Genomic Instability
05/2022
1Breast Neoplasms (Breast Cancer)
02/2022
1Rheumatoid Arthritis
01/2022
1Infections
01/2022
1Bites and Stings (Sting)
01/2022
1Skin Neoplasms (Skin Cancer)
11/2020
1Severe Acute Respiratory Syndrome
11/2020
1Melanoma (Melanoma, Malignant)
09/2020

Drug/Important Bio-Agent (IBA)

11DNA (Deoxyribonucleic Acid)IBA
05/2022 - 03/2014
3Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2020
3Pharmaceutical PreparationsIBA
02/2022 - 08/2020
3Antiviral Agents (Antivirals)IBA
01/2022 - 11/2020
3ThymineIBA
01/2022 - 08/2015
3benzophenoneIBA
03/2016 - 02/2015
2Oxygen (Dioxygen)IBA
11/2022 - 11/2019
2IronIBA
02/2022 - 08/2020
2EnzymesIBA
02/2022 - 06/2021
2RNA (Ribonucleic Acid)IBA
02/2022 - 07/2020
2Biological ProductsIBA
06/2021 - 08/2017
2pyrimidineIBA
09/2020 - 08/2015
2Singlet OxygenIBA
08/2020 - 08/2017
1MetalsIBA
02/2022
1Viral RNAIBA
02/2022
1Ligases (Synthetase)IBA
02/2022
1NF-kappaB-Inducing KinaseIBA
01/2022
1InterferonsIBA
01/2022
1Ivermectin (Mectizan)FDA Link
10/2021
1Viral ProteinsIBA
10/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
06/2021
1Biomarkers (Surrogate Marker)IBA
11/2020
1Nucleic AcidsIBA
11/2020
1Angiotensin-Converting Enzyme 2IBA
11/2020
1LigandsIBA
11/2020
1PyrimidinonesIBA
09/2020
1temoporfinIBA
08/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2020
1Photosensitizing Agents (Photosensitizers)IBA
08/2020
1NucleosidesIBA
11/2019
1NitroimidazolesIBA
11/2019
1A-Form DNA (A-DNA)IBA
11/2019
1hypericinIBA
08/2017
1LipidsIBA
08/2017
1AcidsIBA
01/2017
1Ketoprofen (Orudis)FDA LinkGeneric
01/2017
1Ibuprofen (Motrin)FDA LinkGeneric
01/2017
1GelsIBA
01/2017
1ProdrugsIBA
07/2016
1HydrogenIBA
03/2016
1Nile BlueIBA
01/2016
15-methyl-2-pyrimidone deoxyribonucleosideIBA
08/2015
1B-Form DNA (B-DNA)IBA
08/2015
1acetophenoneIBA
03/2015

Therapy/Procedure

3Therapeutics
08/2020 - 03/2014
3Photochemotherapy (Photodynamic Therapy)
08/2020 - 07/2016
1Precision Medicine
01/2022